Why Abzena?
Our focused approach.
Our experts will be on hand to discuss how, as a highly specialized, leading complex biologics CDMO, we have the experience to accelerate your path to the clinic or commercialization for mammalian and bioconjugate modalities.
At Abzena, we work to give you the best chance of success by combining over 20 years of expertise with state-of-the-art analytics services to minimize risk downstream.
Discover Abzena’s next-generation platforms and solutions including AbZelectPRO our enhanced cell line development technology that empowers you to deliver transformative therapies with speed, quality, and scalability.
Event Details:
Dates: September 30 – October 2
Location: Basel, Switzerland
Event website: Festival of Biologics Europe 2025
Complete the form below to schedule a meeting and learn how Abzena’s integrated solutions can help accelerate your biologic drug development journey.
Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. We have research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.